BlackRock Health Sciences Term Trust (BMEZ) Stock Price, News & Analysis

Company Overview

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services. Utilizing BlackRock’s fundamental research platform, BMEZ takes both long and, when appropriate, short positions to manage risk and potentially enhance returns. The trust may also employ leverage and derivatives to pursue its investment objectives, subject to its board-approved guidelines.

As a product of BlackRock, Inc., the world’s largest asset manager, BMEZ benefits from the firm’s extensive health sciences research capabilities and global distribution network. Portfolio management is led by a team of seasoned health sciences specialists at BlackRock Advisors, who leverage the firm’s proprietary analytics and risk management infrastructure. Oversight is provided by an independent board of trustees, ensuring that the trust adheres to its stated strategy and governance standards.

Key Stats

• Today's Range: $15.06 to $15.23
• 50-Day Range: $13.94 to $15.12
• 52-Week Range: $12.58 to $16.75
• Volume: 177,179 shs
• Average Volume: 316,218 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 13.20%
• Price Target: N/A
• Consensus Rating: N/A

BMEZ Stock Analysis - Frequently Asked Questions

How have BMEZ shares performed this year?

BlackRock Health Sciences Term Trust's stock was trading at $14.40 at the beginning of 2025. Since then, BMEZ stock has increased by 5.2% and is now trading at $15.1550.

Who are BlackRock Health Sciences Term Trust's major shareholders?

BlackRock Health Sciences Term Trust's top institutional shareholders include Shaker Financial Services LLC, Blue Bell Private Wealth Management LLC, Brown Lisle Cummings Inc. and Apollon Wealth Management LLC. Insiders that own company stock include Saba Capital Management, LP and Christopher Accettella.
View institutional ownership trends.

How do I buy shares of BlackRock Health Sciences Term Trust?

Shares of BMEZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of BlackRock Health Sciences Term Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BlackRock Health Sciences Term Trust investors own include JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Symbotic (SYM), Voya Infrastructure, Industrials and Materials Fund (IDE), PIMCO Dynamic Income Fund (PDI), DoubleLine Income Solutions Fund (DSL), Pimco Dynamic Income Opportunities Fund (PDO) and OneMain (OMF).

Company Calendar

• Record date for 9/30 Dividend: 9/15/2025
• Ex-Dividend for 9/30 Dividend: 9/15/2025
• Dividend Payable: 9/30/2025
• Record date for 10/31 Dividend: 10/15/2025
• Ex-Dividend for 10/31 Dividend: 10/15/2025
• Today: 10/24/2025
• Dividend Payable: 10/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: N/A
• Industry: -
• Sub-Industry: N/A
• Current Symbol: NYSE:BMEZ
• CIK: 1785971
• Web: www.blackrock.com
• Phone: 212-810-5300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: -$66.01 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A